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Abstract Mutations in the human cardiac Na+ channel K
subunit gene (SCN5A) are responsible for Brugada syndrome, an
idiopathic ventricular fibrillation (IVF) subgroup characterized
by right bundle branch block and ST elevation on an
electrocardiogram (ECG). However, the molecular basis of
IVF in subgroups lacking these ECG findings has not been
elucidated. We performed genetic screenings of Japanese IVF
patients and found a novel SCN5A missense mutation (S1710L)
in one symptomatic IVF patient that did not exhibit the typical
Brugada ECG. Heterologously expressed S1710L channels
showed marked acceleration in the current decay together with
a large hyperpolarizing shift of steady-state inactivation and
depolarizing shift of activation. These findings suggest that
SCN5A is one of the responsible genes for IVF patients
who do not show typical ECG manifestations of the Brugada
syndrome. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Idiopathic ventricular ¢brillation (IVF) is a syndrome that
causes sudden cardiac death in individuals with an apparently
normal heart [1]. Brugada syndrome is de¢ned as an IVF
characterized by right bundle branch block (RBBB) and ST
segment elevation in leads V1^V3 on an electrocardiogram
(ECG) and a hereditary occurrence is suggested in some pa-
tients [2]. A responsible gene for Brugada syndrome geneti-
cally demonstrated so far is the cardiac Na channel K sub-
unit gene (SCN5A), and several missense mutations including
T1620M, splice-donor, frameshift mutations [3], and an inser-
tion mutation [4] have been identi¢ed.
Despite signi¢cant insight into pathophysiology of IVF pro-
vided by recent molecular biological studies, there are issues
remain to be elucidated. ST elevation of ECG in Brugada
syndrome patients tends to £uctuate with time during fol-
low-up, and the underlying precise mechanisms are still ob-
scure although the autonomic nervous system is considered to
play pivotal roles in this phenomenon. Furthermore, it has
been clinically recognized that there is at least another sub-
group in IVF that lacks electrophysiological manifestations
characterized for the Brugada syndrome. It is not clear, there-
fore, whether these subgroup patients have mutations in
SCN5A with subtle biophysical abnormalities, or alterna-
tively, they may have a genetic basis distinct from the Bruga-
da syndrome.
In order to address these issues, we have genetically
screened IVF patients of both subgroups with and without
typical ECG ¢ndings of Brugada syndrome. A novel missense
mutation (S1710L) in SCN5A was found in a symptomatic
patient of the latter group. Heterologously expressed S1710L
mutant Na channel showed alterations in channel inactiva-
tion and activation that could potentially result in a decreased
Na current amplitude.
2. Materials and methods
2.1. Subjects
Twenty-¢ve Japanese IVF patients were genetically screened with
informed consent. A clinical diagnosis of IVF was made based on the
symptoms of at least one episode of syncope and/or cardiac arrest and
documentation of ventricular ¢brillation (VF). Structural heart dis-
eases were excluded by chest X-ray, exercise ECG, echocardiogram,
ventriculography, and coronary angiography. Eighteen patients were
diagnosed as Brugada syndrome [2].
A 39-year-old man VF06, whose SCN5A mutation was further
examined in this study, was admitted to the hospital because of re-
current syncope. His paternal grandfather and a paternal uncle had
died suddenly in their sixth decade of unknown cause, however, pa-
ternal parents and siblings of the patient were asymptomatic. ECG on
admission showed a ¢rst degree A-V block and marginal QRS pro-
longation (0.10 s) without ST elevation (Fig. 1A), but changed to
complete RBBB with junctional ST elevation in V1 (Fig. 1B) with
increase in heart rate. However, coved or saddleback type ST eleva-
tions in V1ÿ3, typical ECG patterns characterized for Brugada syn-
drome, have never been documented even during therapy with diso-
pyramide. He had an episode of spontaneous VF attack in the
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hospital that was aborted by de¢brillation (Fig. 1C). Clinical elec-
trophysiological study showed H-V prolongation, and VF was
inducible by burst pacing from the right ventricular apex. After a
cardiac de¢brillator was prophylactically implanted, he had no palpi-
tation nor syncope. The proband has no children and other family
members did not agree with further examinations including DNA
diagnostics.
2.2. Polymerase chain reaction-DNA conformation polymorphisms
(PCR-DCP) analysis and DNA sequencing
Genomic DNA was extracted from peripheral blood leukocytes. All
28 exons of SCN5A were ampli¢ed by PCR using primers designed by
Wang et al. [5], and analyzed by PCR-DCP as reported previously [6].
The PCR product showing an aberrant conformer was subcloned into
pCR2.1 (Invitrogen) and multiple independent clones were sequenced
using ABI 373 DNA sequencer (Applied Biosystems).
2.3. Functional expression
Site-directed mutagenesis of the human heart sodium channel K
subunit (hH1) was performed as described [7]. S1710L mutant and
wild type (WT) cDNAs were subcloned into pRcCMV plasmid (In-
vitrogen). Human embryonic kidney cells stably expressing human
Na channel L1 subunit (HEK-hL1) [8] were transiently transfected
with either WT or S1710L cDNA. Cells were cotransfected with a
plasmid encoding CD8 to visually identify cells expressing heterolo-
gous a subunit cDNA with Dynabeads M-450 CD8 (Dynal). Na
currents were recorded using the whole-cell patch clamp technique
based on the methods previously described [9]. An Axopatch 200B
Fig. 1. ECG of the patient VF06. A: ECG on admission shows no ST elevation nor RBBB but marginal QRS prolongation to 0.10 s. B: Junc-
tional ST elevation with complete RBBB with mild tachycardia was observed 2 h after admission. C: Monitor tracings exhibiting the onset of
polymorphic VT later degenerated into VF and terminated by DC shock.
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patch clamp ampli¢er was used to measure whole-cell currents with
series resistance compensation (Axon Instruments). The holding po-
tential for all pulse protocols was 3150 mV. Pipette resistance was
1.0^2.5 M6. The bath solution contained 36 mM NaCl, 109 mM N-
methyl glucamine, 4 mM KCl, 1.8 mM CaCl2, 1.0 mM MgCl2, 10
mM HEPES, and 10 mM glucose, pH 7.35. The pipette solution
contained 10 mM NaF, 110 mM CsF, 20 mM CsCl, 10 mM
EGTA, and 10 mM HEPES, pH 7.35. Voltage-clamp command pulses
were generated using pCLAMP6 (Axon Instruments) and currents
were ¢ltered at 5 kHz (33 dB, 4-pole Bessel ¢lter). Experiments
were done at room temperature (20^22‡C) unless otherwise stated.
The data were analyzed using Clamp¢t (Axon Instruments) and Sig-
maPlot (SPSS Science). Results are presented as means þ S.E.M. and
the statistical comparisons were made using the unpaired Student’s
t-test to evaluate the signi¢cance of the di¡erence between means.
Statistical signi¢cance was assumed for P6 0.05.
3. Results
3.1. Molecular genetics
PCR-DCP analysis showed an aberrant band in exon 28 of
an IVF patient (VF06, Fig. 2A). This pattern was not ob-
served for 300 normal chromosomes, consistent with a dis-
ease-related mutation. DNA sequencing con¢rmed a C to T
transition leading to amino acid substitution of leucine for
serine 1710 (S1710L; Fig. 2B), located at the pore-forming
loop (P-loop) between segments 5 and 6 of domain 4. Amino
acid sequence alignment shows that the P-loop of D4 is highly
conserved among di¡erent Na channel isoforms and the res-
idues corresponding to the S1710 of SCN5A are identical
among them (Fig. 3). The heterozygous state of this patient
was con¢rmed by direct sequencing of the PCR products from
genomic DNA (data not shown). No other SCN5A mutations
were found in the patient V06. The other 24 IVF patients did
not show aberrant bands on DCP analysis for any exons of
SCN5A.
3.2. Functional analysis of the S1710L mutation
In the absence of further genetic data on this family, we
chose to determine whether the mutation a¡ects sodium chan-
nel function. This was accomplished by expressing a recombi-
nant human heart sodium channel in a heterologous cell line
and recording currents with the whole-cell patch clamp tech-
nique. One remarkable biophysical property observed for the
macroscopic Na currents of heterologously expressed
S1710L channel is the accelerated current decay (Fig. 4A).
Fig. 2. A: PCR-DCP analysis of exon 28. Genomic DNAs from
IVF patients were ampli¢ed by the PCR for exon 28 and the PCR
products were electrophoresed in an 8% polyacrylamide gel after
heat denaturation. Lanes 1^5: patients with Brugada syndrome,
lanes 6^8: IVF patients without Brugada syndrome-type ECG, lanes
9^12: healthy controls. An abnormal DCP fragment shown by an
arrow was found in the patient VF06 (lane 6). B: DNA sequencing
data of SCN5A clones from VF06. Sequences of clones representing
normal (left) and abnormal DCP patterns (right) are shown. The
mutant clone had a C to T transition.
Fig. 3. A: SCN5A mutations in inherited cardiac arrhythmia. The predicted topology of cardiac Na channel is illustrated with location of
known mutations associated with either LQT3 (a) or Brugada syndrome (b). B: Amino acid sequence alignments of SCN5A with related Na
channel sequences are shown in the lower panel (SCN5A: human heart [M77235], SCN1A: human brain type I [X65362], SCN2A: human
brain type II [M94055], SCN4A: human skeletal muscle [M81758], SCN5a: rat heart [M27902], Eel: eel electroplax [M22252], Squid: squid
axon [L19979]; GenBank accession numbers are given in square brackets). The asterisk indicates the alanine located at the P-loop of D4, one
of the responsible residues for the ion selectivity ¢lter of voltage^gate Na channels.
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The time course of inactivation ¢t with a two-exponential
function revealed that the fraction of rapidly inactivating
component (Af ) was signi¢cantly larger and the time con-
stants of fast components (df ) were signi¢cantly smaller in
S1710L than in WT at test pulse voltages between 340 mV
and +30 mV (Fig. 4B). Since it was recently reported that a
higher temperature unmasks the abnormalities of channel ki-
netics in a Brugada syndrome mutant Na channel T1620M
[10], we tried patch clamp experiments at 32‡C. Macroscopic
current decay at 32‡C was signi¢cantly faster for both WT
and S1710L channels than at room temperature, however,
S1710L displayed current decay even faster than WT, suggest-
ing that the time course of inactivation of S1710L was signi¢-
cantly faster than WT regardless of the temperature (unpub-
lished observation, Shirai et al.). We did not carry out further
experiments under these conditions because capacitance com-
pensation tended to become too di⁄cult to obtain consistent
and reliable data as temperature increased. Moreover, com-
parable functional abnormalities of S1710L were shown by
patch clamp studies using native HEK cells without transfec-
tion of L1 subunit and two-electrode voltage clamp experi-
ments using Xenopus oocytes (data not shown), suggesting
that S1710L does not exhibit phenotypic discrepancies de-
pending on the expression system [11] or kinetic modi¢cations
by co-expressed L1 subunit [12] demonstrated in the T1620M
mutant channel.
The voltage dependence of steady-state inactivation of
S1710L was signi¢cantly shifted towards more negative poten-
tial by nearly 25 mV (V1=2 : WT =380.8 þ 2.1 mV, n = 9;
S1710L: 3105.1 þ 2.4 mV, n = 9; P6 0.001) and the slope
factors were signi¢cantly larger in S1710L (k : WT =
7.7 þ 0.18, S1710L = 8.5 þ 0.24, P6 0.05) (Fig. 5A). Con-
versely, the voltage-dependence of activation of S1710L was
signi¢cantly shifted towards a more positive potential by V18
mV (V1=2 : WT =344.1 þ 0.3 mV, S1710L: 326.4 þ 0.9 mV;
P6 0.001) and the slope factors were signi¢cantly larger
(k : WT = 7.6 þ 0.23, S1710L = 8.5 þ 0.28; P6 0.05). Conse-
quently, S1710L channels have severe functional defects re-
sulting in substantially smaller overlap in the relationship be-
tween channel inactivation and activation (window current).
The time course of recovery from inactivation was signi¢-
cantly slower in S1710L than in WT (Fig. 5B). The time con-
stant of fast recovery component (df ) was signi¢cantly larger
in S1710L (3.2 þ 0.29 ms, n = 8) than in WT (1.6 þ 0.17 ms,
n = 10) (P6 0.001). The time constant of slow recovery com-
ponent (ds ; WT = 27.7 þ 4.9 ms, S1710L = 33.3 þ 4.5 ms), and
the fractions of fast recovery component (Af ; WT =
0.83 þ 0.02, S1710L = 0.84 þ 0.02) and slow recovery compo-
nent (As ; WT = 0.15 þ 0.02, S1710L = 0.16 þ 0.04) were com-
parable.
4. Discussion
In this study, we have identi¢ed a novel SCN5A missense
mutation S1710L in an IVF patient who lacks documentation
of a typical ECG pattern of the Brugada syndrome (coved or
saddleback type ST elevations in V1ÿ3). It has been a matter
of controversy whether this IVF subgroup is a phenotypic
variation of the Brugada syndrome or a disease entity clini-
cally and genetically distinct from the Brugada syndrome,
because ECGs of Brugada syndrome patients are profoundly
a¡ected by an autonomic nervous system tone [13] and exhibit
time-dependent changes with occasional normalization. Gen-
otype^phenotype co-segregation data are not available in this
study, however, identi¢cation of a novel mutation of SCN5A
associated with a symptomatic IVF patient who lacks docu-
Fig. 4. A: Representative whole-cell current records obtained from HEK-hL1 cells transfected with either WT or S1710L Na channels. Cur-
rents were recorded from a holding potential of 3150 mV stepped from 390 mV to +90 mV during 20 ms in 10 mV increments. Currents
were normalized and superimposed to illustrate di¡erences in the time course of current decay. B: The time course of inactivation was ¢t with
a two-exponential function: It/Imax = Ar+AfUexp(3t/df )+AsUexp(3t/ds), where Ar is a constant value, Af and As are the fractions of fast and
slow inactivating components, df and ds are the time constants of fast and slow inactivating components, respectively. The fraction of fast com-
ponent (Af ) is shown in the upper panel, and the fast time constants (df , squares) and the slow time constant (ds, circles) are illustrated in the
lower panel. Statistical signi¢cance in the di¡erence between WT (open, n = 10) and S1710L (solid, n = 9) are shown (*P6 0.05, **P6 0.01).
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mentation of a typical ECG of the Brugada syndrome has
genetic relevance indicating that Brugada syndrome and this
IVF subgroup are at least genetically overlapped, and possibly
allelic disorders resulting from defects of SCN5A like LQT3
form of congenital long QT syndrome and hereditary A-V
block [14].
Biophysical properties of the S1710L mutant Na channels
are: (1) accelerated time course of inactivation, (2) hyperpo-
larizing shift of steady-state inactivation curve, (3) depolariz-
ing shift of activation curve, and (4) delayed recovery from
inactivation. Based on these ¢ndings, it is expected that the
mutant S1710L channels enter the inactivated state from open
state with signi¢cantly faster rates than WT, and the avail-
ability for opening was markedly reduced at membrane po-
tentials negative to the activation threshold (V350 mV for
normal heart), while the activation threshold itself was signi¢-
cantly elevated in S1710L compared to WT (Fig. 3C). These
biophysical properties could potentially result in a decrease of
net Na currents at each cardiac cycle, and are compatible
with the electrophysiological conduction disturbance clinically
observed for the patient VF06 (H-V prolongation, rate-depen-
dent RBBB and intraventricular conduction disturbance).
Furthermore, a decrease in the Na current will cause an
outward shift of the current active at the end of phase 1,
and a marked abbreviation of action potential in the epicar-
dium but not in the endocardium, because the transient out-
ward K current (It) is predominantly expressed in epicardi-
um, which in turn creates a transmural voltage gradient
during repolarization and disparity of the refractory period,
and provides the substrate reentry [15,16]. However, the lack
of ST elevation in ECG of this patient cannot be veri¢ed by
the above explanation and is to be further delineated.
Enhanced inactivation due to accelerated current decay is
not a unique feature speci¢cally observed for S1710L. Similar
channel property was observed in Brugada syndrome muta-
tion T1620M, although only at higher temperature, and was
regarded as one of the relevant mechanisms for ST elevation
[10]. Clinically, however, the patients with a T1620M muta-
tion showed a typical ECG pattern of the Brugada syndrome,
while the patient with a S1710L mutation did not. These
¢ndings suggest that an accelerated time course of inactiva-
tion per se may not be the primary mechanism of the ECG
signature of Brugada syndrome.
Brugada syndrome and the LQT3 form of congenital long
QT syndrome are allelic disorders resulting from the defects of
SCN5A. Persistent Na currents due to dysfunctional channel
inactivation are commonly observed for most LQT3 mutant
channels and regarded as the molecular basis of QT prolon-
gation in LQT3 [17]. In contrast, the molecular mechanisms
underlying Brugada syndrome and other IVF appear more
complicated, because heterologously expressed mutant Na
channels reported so far exhibit a wide variety of functional
properties ; for instance, T1620M mutation gives rise to a
depolarizing shift of the steady-state inactivation curve [3,12]
with an accelerated current decay only at higher temperatures
[10], while the R1512W mutant showed a hyperpolarizing shift
of steady-state activation and inactivation, and A1924T
caused a negative shift of the activation curve alone [18].
Moreover, an in-frame stop codon in the D4/S6 region results
in a non-functional channel [3]. Furthermore, it is still obscure
why the dysfunctional heterologously expressed S1710L chan-
nels appear more severe than most other Brugada syndrome
mutations while the ECG abnormalities of S1710L apparently
seem more subtle than those of the Brugada syndrome.
The residue S1710 of hH1 is located at the P-loop between
S5 and S6 of domain 4 and the corresponding residue is
highly conserved among di¡erent Na channel isoforms
(Fig. 3). Recent structure^function studies have revealed
that S1710 is located at the deepest region of the P-loop. It
is believed that the ion selectivity of the Na channel is de-
termined by a ring of amino acids of P-loops of all four
domains [19,20] and the major determinants are the residues
so-called ‘DEKA’ (D372, E898, K1419, and A1711 of the
hH1 sequence). Since S1710 is adjacent to the residue
A1711, it is speculated that the mutant Na channel S1710L
may have additional functional alterations such as in ion per-
meation properties. These issues are currently being investi-
gated.
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